Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes

Author： Jonsson Malin KB van Veen Toon AB Goumans Marie-Jose Vos Marc A Duker Göran Sartipy Peter

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.4, 2009-04, pp. : 357-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human embryonic stem cell-derived cardiomyocytes: drug discovery and safety pharmacology

By He Jia-Qiang January Craig T Thomson James A Kamp Timothy J

Expert Opinion on Drug Discovery, Vol. 2, Iss. 5, 2007-05 ,pp. : 739-753

Informa Healthcare

Access to resources Recommend Favorite

Can stem-cell-derived models revolutionize drug discovery?

By Landgren Henrik Sartipy Peter

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 9-13

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Efficacy and Safety Outcomes of Transplantation of Induced Pluripotent Stem Cell-Derived Neurospheres with Bioabsorbable Nerve Conduits for Peripheral Nerve Regeneration in Mice

Cells Tissues Organs, Vol. 200, Iss. 1, 2015-03 ,pp. : 78-91

Karger

Access to resources Recommend Favorite

Embryonic Stem Cell-Derived Adipogenesis

Cells Tissues Organs, Vol. 165, Iss. 3-4, 1999-12 ,pp. : 173-180

Karger

Access to resources Recommend Favorite

Embryonic Stem Cell-Derived Haematopoiesis

Cells Tissues Organs, Vol. 165, Iss. 3-4, 1999-12 ,pp. : 181-189

Karger

Access to resources Recommend Favorite